We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » OIG Urges FDA to Strengthen Investigator Financial Oversight
OIG Urges FDA to Strengthen Investigator Financial Oversight
January 2, 2013
The HHS Office of Inspector General (OIG) is once again urging the FDA to require that sponsors submit clinical investigator financial information as part of the pretrial application process.